The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

L-alpha-Glycerylphosphorylcholine     2-[[(2R)-2,3- dihydroxypropoxy]-hydroxy...

Synonyms: DB04660, AC1L971T, C00670, CH5, Glycerophosphocholine, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of L-alpha-Glycerylphosphorylcholine

 

Psychiatry related information on L-alpha-Glycerylphosphorylcholine

 

High impact information on L-alpha-Glycerylphosphorylcholine

 

Chemical compound and disease context of L-alpha-Glycerylphosphorylcholine

 

Biological context of L-alpha-Glycerylphosphorylcholine

 

Anatomical context of L-alpha-Glycerylphosphorylcholine

  • (Chilton, F. H., Ellis, J. M., Olson, S. C., and Wykle, R. L. (1984) J. Biol. Chem. 259, 12014-12019) indicate that in human neutrophils the metabolism of alkenylacyl-GPE and alkylacyl-sn-glycero-3-phosphocholine (GPC) are strikingly similar with regard to arachidonate metabolism [23].
  • We confirm that ionophore A23187 induces substantial [(3)H]arachidonate release from differentiated but not control U937 cells, and electrospray ionization mass spectrometric (ESI/MS) analyses indicate that differentiated cells contain a higher proportion of arachidonate-containing GPC species than control cells [24].
  • Testes or other tissues of iPLA(2)beta(-/-) mice express no iPLA(2)beta mRNA or protein, but iPLA(2)beta(-/-) testes are not deficient in 20:4-containing glycerophosphocholine lipids, indicating that iPLA(2)beta does not play an obligatory role in formation of such lipids in that tissue [19].
  • Eukaryotic cells control the levels of their major membrane lipid, phosphatidylcholine (PtdCho), by balancing synthesis with degradation via deacylation to glycerophosphocholine (GroPCho) [25].
  • Previous studies have not recognized that phosphocholine and glycerophosphocholine exist in human milk [26].
 

Associations of L-alpha-Glycerylphosphorylcholine with other chemical compounds

 

Gene context of L-alpha-Glycerylphosphorylcholine

 

Analytical, diagnostic and therapeutic context of L-alpha-Glycerylphosphorylcholine

References

  1. Molecular causes of the aberrant choline phospholipid metabolism in breast cancer. Glunde, K., Jie, C., Bhujwalla, Z.M. Cancer Res. (2004) [Pubmed]
  2. Raised concentrations of platelet activating factor in colonic mucosa of Crohn's disease patients. Sobhani, I., Hochlaf, S., Denizot, Y., Vissuzaine, C., Rene, E., Benveniste, J., Lewin, M.M., Mignon, M. Gut (1992) [Pubmed]
  3. Core aldehydes of alkyl glycerophosphocholines in atheroma induce platelet aggregation and inhibit endothelium-dependent arterial relaxation. Kamido, H., Eguchi, H., Ikeda, H., Imaizumi, T., Yamana, K., Hartvigsen, K., Ravandi, A., Kuksis, A. J. Lipid Res. (2002) [Pubmed]
  4. Involvement of PPARgamma in oxidative stress-mediated prostaglandin E(2) production in SZ95 human sebaceous gland cells. Zhang, Q., Seltmann, H., Zouboulis, C.C., Konger, R.L. J. Invest. Dermatol. (2006) [Pubmed]
  5. Simple assay for glycerophospholipid hydrolase activity of postheparin plasma. Shaw, W.A., Harlan, W.R. J. Lipid Res. (1977) [Pubmed]
  6. Brain proton magnetic resonance spectroscopy (1H-MRS) in Alzheimer's disease: changes after treatment with xanomeline, an M1 selective cholinergic agonist. Satlin, A., Bodick, N., Offen, W.W., Renshaw, P.F. The American journal of psychiatry. (1997) [Pubmed]
  7. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial. De Jesus Moreno Moreno, M. Clinical therapeutics. (2003) [Pubmed]
  8. L-alpha-glycerylphosphorylcholine antagonizes scopolamine-induced amnesia and enhances hippocampal cholinergic transmission in the rat. Sigala, S., Imperato, A., Rizzonelli, P., Casolini, P., Missale, C., Spano, P. Eur. J. Pharmacol. (1992) [Pubmed]
  9. Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor. Zhang, Q., Mousdicas, N., Yi, Q., Al-Hassani, M., Billings, S.D., Perkins, S.M., Howard, K.M., Ishii, S., Shimizu, T., Travers, J.B. J. Clin. Invest. (2005) [Pubmed]
  10. GDE1/MIR16 is a glycerophosphoinositol phosphodiesterase regulated by stimulation of G protein-coupled receptors. Zheng, B., Berrie, C.P., Corda, D., Farquhar, M.G. Proc. Natl. Acad. Sci. U.S.A. (2003) [Pubmed]
  11. Factors affecting counteraction by methylamines of urea effects on aldose reductase. Burg, M.B., Peters, E.M., Bohren, K.M., Gabbay, K.H. Proc. Natl. Acad. Sci. U.S.A. (1999) [Pubmed]
  12. Phospholipase D-catalyzed hydrolysis of phosphatidylcholine provides the choline precursor for acetylcholine synthesis in a human neuronal cell line. Lee, H.C., Fellenz-Maloney, M.P., Liscovitch, M., Blusztajn, J.K. Proc. Natl. Acad. Sci. U.S.A. (1993) [Pubmed]
  13. Evidence for a membrane defect in Alzheimer disease brain. Nitsch, R.M., Blusztajn, J.K., Pittas, A.G., Slack, B.E., Growdon, J.H., Wurtman, R.J. Proc. Natl. Acad. Sci. U.S.A. (1992) [Pubmed]
  14. Characterization of choline compounds with in vitro 1H magnetic resonance spectroscopy for the discrimination of primary brain tumors. Sabatier, J., Gilard, V., Malet-Martino, M., Ranjeva, J.P., Terral, C., Breil, S., Delisle, M.B., Manelfe, C., Tremoulet, M., Berry, I. Investigative radiology. (1999) [Pubmed]
  15. Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients. Blusztajn, J.K., Lopez Gonzalez-Coviella, I., Logue, M., Growdon, J.H., Wurtman, R.J. Brain Res. (1990) [Pubmed]
  16. Epididymal markers in human infertility. Cooper, T.G., Yeung, C.H., Nashan, D., Nieschlag, E. J. Androl. (1988) [Pubmed]
  17. Effect of propylthiouracil-induced hypothyroidism on cerebral cortex of young and aged rats: lipid composition of synaptosomes, muscarinic receptor sites, and acetylcholinesterase activity. Salvati, S., Attorri, L., Campeggi, L.M., Olivieri, A., Sorcini, M., Fortuna, S., Pintor, A. Neurochem. Res. (1994) [Pubmed]
  18. Activation, inhibition, and regiospecificity of the lysophospholipase activity of the 85-kDa group IV cytosolic phospholipase A2. Loo, R.W., Conde-Frieboes, K., Reynolds, L.J., Dennis, E.A. J. Biol. Chem. (1997) [Pubmed]
  19. Male mice that do not express group VIA phospholipase A2 produce spermatozoa with impaired motility and have greatly reduced fertility. Bao, S., Miller, D.J., Ma, Z., Wohltmann, M., Eng, G., Ramanadham, S., Moley, K., Turk, J. J. Biol. Chem. (2004) [Pubmed]
  20. Glycerophosphocholine-dependent growth requires Gde1p (YPL110c) and Git1p in Saccharomyces cerevisiae. Fisher, E., Almaguer, C., Holic, R., Griac, P., Patton-Vogt, J. J. Biol. Chem. (2005) [Pubmed]
  21. Isoleukotrienes are biologically active free radical products of lipid peroxidation. Harrison, K.A., Murphy, R.C. J. Biol. Chem. (1995) [Pubmed]
  22. Ethanolamine and phosphoethanolamine inhibit mitochondrial function in vitro: implications for mitochondrial dysfunction hypothesis in depression and bipolar disorder. Modica-Napolitano, J.S., Renshaw, P.F. Biol. Psychiatry (2004) [Pubmed]
  23. Selective deacylation of arachidonate-containing ethanolamine-linked phosphoglycerides in stimulated human neutrophils. Tessner, T.G., Greene, D.G., Wykle, R.L. J. Biol. Chem. (1990) [Pubmed]
  24. Electrospray ionization/mass spectrometric analyses of human promonocytic U937 cell glycerolipids and evidence that differentiation is associated with membrane lipid composition changes that facilitate phospholipase A2 activation. Hsu, F.F., Ma, Z., Wohltmann, M., Bohrer, A., Nowatzke, W., Ramanadham, S., Turk, J. J. Biol. Chem. (2000) [Pubmed]
  25. Neuropathy target esterase and its yeast homologue degrade phosphatidylcholine to glycerophosphocholine in living cells. Zaccheo, O., Dinsdale, D., Meacock, P.A., Glynn, P. J. Biol. Chem. (2004) [Pubmed]
  26. Choline and choline esters in human and rat milk and in infant formulas. Holmes-McNary, M.Q., Cheng, W.L., Mar, M.H., Fussell, S., Zeisel, S.H. Am. J. Clin. Nutr. (1996) [Pubmed]
  27. Osmoregulatory changes in myo-inositol transport by renal cells. Nakanishi, T., Turner, R.J., Burg, M.B. Proc. Natl. Acad. Sci. U.S.A. (1989) [Pubmed]
  28. Metabolic consequences of p300 gene deletion in human colon cancer cells. Bundy, J.G., Iyer, N.G., Gentile, M.S., Hu, D.E., Kettunen, M., Maia, A.T., Thorne, N.P., Brenton, J.D., Caldas, C., Brindle, K.M. Cancer Res. (2006) [Pubmed]
  29. In vivo 31P-nuclear magnetic resonance study of the response of a murine mammary tumor to different doses of gamma-radiation. Sijens, P.E., Bovée, W.M., Seijkens, D., Los, G., Rutgers, D.H. Cancer Res. (1986) [Pubmed]
  30. Nte1p-mediated deacylation of phosphatidylcholine functionally interacts with Sec14p. Murray, J.P., McMaster, C.R. J. Biol. Chem. (2005) [Pubmed]
  31. Characterization and function in vivo of two novel phospholipases B/lysophospholipases from Saccharomyces cerevisiae. Merkel, O., Fido, M., Mayr, J.A., Prüger, H., Raab, F., Zandonella, G., Kohlwein, S.D., Paltauf, F. J. Biol. Chem. (1999) [Pubmed]
  32. Epidermal peroxisome proliferator-activated receptor gamma as a target for ultraviolet B radiation. Zhang, Q., Southall, M.D., Mezsick, S.M., Johnson, C., Murphy, R.C., Konger, R.L., Travers, J.B. J. Biol. Chem. (2005) [Pubmed]
  33. Apolipoprotein A-I promotes the formation of phosphatidylcholine core aldehydes that are hydrolyzed by paraoxonase (PON-1) during high density lipoprotein oxidation with a peroxynitrite donor. Ahmed, Z., Ravandi, A., Maguire, G.F., Emili, A., Draganov, D., La Du, B.N., Kuksis, A., Connelly, P.W. J. Biol. Chem. (2001) [Pubmed]
  34. Alkyl-lysophospholipid 1-O-octadecyl-2-O-methyl- glycerophosphocholine induces invasion through episialin-mediated neutralization of E-cadherin in human mammary MCF-7 cells in vitro. Steelant, W.F., Goeman, J.L., Philippé, J., Oomen, L.C., Hilkens, J., Krzewinski-Recchi, M.A., Huet, G., Van der Eycken, J., Delannoy, P., Bruyneel, E.A., Mareel, M.M. Int. J. Cancer (2001) [Pubmed]
  35. Posttranscriptional regulation of Git1p, the glycerophosphoinositol/glycerophosphocholine transporter of Saccharomyces cerevisiae. Almaguer, C., Fisher, E., Patton-Vogt, J. Curr. Genet. (2006) [Pubmed]
  36. In vitro and in vivo 31P nuclear magnetic resonance measurements of metabolic changes post radiation. Mahmood, U., Alfieri, A.A., Ballon, D., Traganos, F., Koutcher, J.A. Cancer Res. (1995) [Pubmed]
  37. Analysis of glycerophosphocholine molecular species as derivatives of 7-[(chlorocarbonyl)-methoxy]-4-methylcoumarin. Wheelan, P., Zirrolli, J.A., Clay, K.L. J. Lipid Res. (1992) [Pubmed]
  38. Analysis of oxidized glycerophosphocholine lipids using electrospray ionization mass spectrometry and microderivatization techniques. Harrison, K.A., Davies, S.S., Marathe, G.K., McIntyre, T., Prescott, S., Reddy, K.M., Falck, J.R., Murphy, R.C. Journal of mass spectrometry : JMS. (2000) [Pubmed]
  39. The metabolism of 1-acyl-PAF in rabbit platelets and its possible interaction with PAF. Touqui, L., Silva, C.S., Vargaftig, B.B. Lipids (1991) [Pubmed]
  40. The effect of free fatty acids on the thermotropic phase transition of dimyristoyl glycerophosphocholine. Usher, J.R., Epand, R.M., Papahadjopoulos, D. Chem. Phys. Lipids (1978) [Pubmed]
 
WikiGenes - Universities